184 related articles for article (PubMed ID: 27693595)
1. Biomarker Development in COPD: Moving From P Values to Products to Impact Patient Care.
Hollander Z; DeMarco ML; Sadatsafavi M; McManus BM; Ng RT; Sin DD
Chest; 2017 Feb; 151(2):455-467. PubMed ID: 27693595
[TBL] [Abstract][Full Text] [Related]
2. Blood and sputum protein biomarkers for chronic obstructive pulmonary disease (COPD).
Moon JY; Leitao Filho FS; Shahangian K; Takiguchi H; Sin DD
Expert Rev Proteomics; 2018 Nov; 15(11):923-935. PubMed ID: 30362838
[TBL] [Abstract][Full Text] [Related]
3. Biomarker Development for Chronic Obstructive Pulmonary Disease. From Discovery to Clinical Implementation.
Sin DD; Hollander Z; DeMarco ML; McManus BM; Ng RT
Am J Respir Crit Care Med; 2015 Nov; 192(10):1162-70. PubMed ID: 26176936
[TBL] [Abstract][Full Text] [Related]
4. Clinical Drug Development Using Dynamic Biomarkers to Enable Personalized Health Care in COPD.
Bihlet AR; Karsdal MA; Bay-Jensen AC; Read S; Kristensen JH; Sand JMB; Leeming DJ; Andersen JR; Lange P; Vestbo J
Chest; 2015 Jul; 148(1):16-23. PubMed ID: 25856563
[TBL] [Abstract][Full Text] [Related]
5. Procalcitonin Biomarker Algorithm Reduces Antibiotic Prescriptions, Duration of Therapy, and Costs in Chronic Obstructive Pulmonary Disease: A Comparison in the Netherlands, Germany, and the United Kingdom.
van der Maas ME; Mantjes G; Steuten LM
OMICS; 2017 Apr; 21(4):232-243. PubMed ID: 28388301
[TBL] [Abstract][Full Text] [Related]
6. The Challenges of Precision Medicine in COPD.
Cazzola M; Calzetta L; Rogliani P; Matera MG
Mol Diagn Ther; 2017 Aug; 21(4):345-355. PubMed ID: 28247183
[TBL] [Abstract][Full Text] [Related]
7. Sex and Gender Omic Biomarkers in Men and Women With COPD: Considerations for Precision Medicine.
DeMeo DL
Chest; 2021 Jul; 160(1):104-113. PubMed ID: 33745988
[TBL] [Abstract][Full Text] [Related]
8. Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.
Singh D; Roche N; Halpin D; Agusti A; Wedzicha JA; Martinez FJ
Am J Respir Crit Care Med; 2016 Sep; 194(5):541-9. PubMed ID: 27585383
[TBL] [Abstract][Full Text] [Related]
9. Exhaled nitric oxide measure using multiple flows in clinically relevant subgroups of COPD.
Bazeghi N; Gerds TA; Budtz-Jørgensen E; Hove J; Vestbo J
Respir Med; 2011 Sep; 105(9):1338-44. PubMed ID: 21530214
[TBL] [Abstract][Full Text] [Related]
10. Identification of MMP-9 as a biomarker for detecting progression of chronic obstructive pulmonary disease.
Abd El-Fatah MF; Ghazy MA; Mostafa MS; El-Attar MM; Osman A
Biochem Cell Biol; 2015 Dec; 93(6):541-7. PubMed ID: 26291981
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers in obstructive respiratory diseases: an update.
Braido F; Bagnasco D; Scichilone N; Santus P; Solidoro P; Di Marco F; Corsico A; Canonica GW
Panminerva Med; 2012 Jun; 54(2):119-27. PubMed ID: 22525566
[TBL] [Abstract][Full Text] [Related]
12. Profiling serum biomarkers in patients with COPD: associations with clinical parameters.
Pinto-Plata V; Toso J; Lee K; Park D; Bilello J; Mullerova H; De Souza MM; Vessey R; Celli B
Thorax; 2007 Jul; 62(7):595-601. PubMed ID: 17356059
[TBL] [Abstract][Full Text] [Related]
13. Characterization of sputum biomarkers for asthma-COPD overlap syndrome.
Gao J; Iwamoto H; Koskela J; Alenius H; Hattori N; Kohno N; Laitinen T; Mazur W; Pulkkinen V
Int J Chron Obstruct Pulmon Dis; 2016; 11():2457-2465. PubMed ID: 27757028
[TBL] [Abstract][Full Text] [Related]
14. From proteomics to prescription-the search for COPD biomarkers.
Nicholas BL; O'Connor CD; Djukanovic R
COPD; 2009 Aug; 6(4):298-303. PubMed ID: 19811390
[TBL] [Abstract][Full Text] [Related]
15. Systemic biomarkers in the evaluation and management of COPD patients: are we getting closer to clinical application?
Kostikas K; Bakakos P; Papiris S; Stolz D; Celli BR
Curr Drug Targets; 2013 Feb; 14(2):177-91. PubMed ID: 23256717
[TBL] [Abstract][Full Text] [Related]
16. Lipid-based biomarkers for CVD, COPD, and aging - A translational perspective.
Ekroos K; Lavrynenko O; Titz B; Pater C; Hoeng J; Ivanov NV
Prog Lipid Res; 2020 Apr; 78():101030. PubMed ID: 32339553
[TBL] [Abstract][Full Text] [Related]
17. [From COPD definitions to COPD phenotypes].
Burgel PR
Presse Med; 2014 Dec; 43(12 Pt 1):1337-43. PubMed ID: 25448122
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers in Chronic Obstructive Pulmonary Disease: The Gateway to Precision Medicine.
Milne S; Sin DD
Clin Chest Med; 2020 Sep; 41(3):383-394. PubMed ID: 32800193
[TBL] [Abstract][Full Text] [Related]
19. From Systems Understanding to Personalized Medicine: Lessons and Recommendations Based on a Multidisciplinary and Translational Analysis of COPD.
Roca J; Cano I; Gomez-Cabrero D; Tegnér J
Methods Mol Biol; 2016; 1386():283-303. PubMed ID: 26677188
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
